Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shane Atwell

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|March 12, 2025
Quantitative detection of the HVEM-BTLA checkpoint receptor cis-complex in human lymphocytesShane Atwell, Timothy C Cheung, Elaine M Conner, et al.
Structure (London, England : 1993)|June 6, 2023
Epitope topography of agonist antibodies to the checkpoint inhibitory receptor BTLATimothy C Cheung, Shane Atwell, Lisa Bafetti, et al.
The Journal of Biological Chemistry|December 3, 2015
Channel Gating Regulation by the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) First Cytosolic LoopAnnette Ehrhardt, W Joon Chung, Louise C Pyle, et al.
Nature Biotechnology|January 28, 2014
Generation of bispecific IgG antibodies by structure-based design of an orthogonal Fab interfaceSteven M Lewis, Xiufeng Wu, Anna Pustilnik, et al.
Protein Science : a Publication of the Protein Society|November 9, 2023
Engineered antigen-binding fragments for enhanced crystallization of antibody:antigen complexesHeather A Bruce, Alexander U Singer, Ekaterina V Filippova, et al.
Mabs|June 12, 2019
Development of tibulizumab, a tetravalent bispecific antibody targeting BAFF and IL-17A for the treatment of autoimmune diseaseRobert J Benschop, Chi-Kin Chow, Yu Tian, et al.
Protein Engineering, Design & Selection : PEDS|February 13, 2010
Structures of a minimal human CFTR first nucleotide-binding domain as a monomer, head-to-tail homodimer, and pathogenic mutantShane Atwell, Christie G Brouillette, Kris Conners, et al.
Journal of Molecular Biology|February 17, 2010
Structures of PHR domains from Mus musculus Phr1 (Mycbp2) explain the loss-of-function mutation (Gly1092-->Glu) of the C. elegans ortholog RPM-1Parthasarathy Sampathkumar, Sinem A Ozyurt, Stacy A Miller, et al.
The Journal of Biological Chemistry|October 28, 2004
A novel mode of Gleevec binding is revealed by the structure of spleen tyrosine kinaseShane Atwell, Jason M Adams, John Badger, et al.
Proteins|May 1, 2012
Atomic structure of the nuclear pore complex targeting domain of a Nup116 homologue from the yeast, Candida glabrataParthasarathy Sampathkumar, Seung Joong Kim, Danalyn Manglicmot, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Journal of Immunology (Baltimore, Md. : 1950)|March 12, 2025
Quantitative detection of the HVEM-BTLA checkpoint receptor cis-complex in human lymphocytesShane Atwell, Timothy C Cheung, Elaine M Conner, et al.
Structure (London, England : 1993)|June 6, 2023
Epitope topography of agonist antibodies to the checkpoint inhibitory receptor BTLATimothy C Cheung, Shane Atwell, Lisa Bafetti, et al.
The Journal of Biological Chemistry|December 3, 2015
Channel Gating Regulation by the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) First Cytosolic LoopAnnette Ehrhardt, W Joon Chung, Louise C Pyle, et al.
Nature Biotechnology|January 28, 2014
Generation of bispecific IgG antibodies by structure-based design of an orthogonal Fab interfaceSteven M Lewis, Xiufeng Wu, Anna Pustilnik, et al.
Protein Science : a Publication of the Protein Society|November 9, 2023
Engineered antigen-binding fragments for enhanced crystallization of antibody:antigen complexesHeather A Bruce, Alexander U Singer, Ekaterina V Filippova, et al.
Mabs|June 12, 2019
Development of tibulizumab, a tetravalent bispecific antibody targeting BAFF and IL-17A for the treatment of autoimmune diseaseRobert J Benschop, Chi-Kin Chow, Yu Tian, et al.
Protein Engineering, Design & Selection : PEDS|February 13, 2010
Structures of a minimal human CFTR first nucleotide-binding domain as a monomer, head-to-tail homodimer, and pathogenic mutantShane Atwell, Christie G Brouillette, Kris Conners, et al.
Journal of Molecular Biology|February 17, 2010
Structures of PHR domains from Mus musculus Phr1 (Mycbp2) explain the loss-of-function mutation (Gly1092-->Glu) of the C. elegans ortholog RPM-1Parthasarathy Sampathkumar, Sinem A Ozyurt, Stacy A Miller, et al.
The Journal of Biological Chemistry|October 28, 2004
A novel mode of Gleevec binding is revealed by the structure of spleen tyrosine kinaseShane Atwell, Jason M Adams, John Badger, et al.
Proteins|May 1, 2012
Atomic structure of the nuclear pore complex targeting domain of a Nup116 homologue from the yeast, Candida glabrataParthasarathy Sampathkumar, Seung Joong Kim, Danalyn Manglicmot, et al.
Pageof 3